Liverpool Hospital

Sydney NSW2170

3 studies enrolling now · 8 studies all time

What they study most

Extensive-stage Small-cell Lung Cancer, FSGS, Follicular Lymphoma (FL), Hemolytic Disease of the Fetus and Newborn, Latent Tuberculosis, Marginal Zone Lymphoma, Non Hodgkin Lymphoma, Pyoderma Gangrenosum, Wounds and Injuries

Studies at this site

• A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) — Recruiting now
• Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
• Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI — Recruiting now
• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN) — Completed
• Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum — Stopped early
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• Splenic Injury Embolization - the Question About NOM (SInE Qua NOM) — Status unconfirmed